0001415889-23-007669.txt : 20230509 0001415889-23-007669.hdr.sgml : 20230509 20230509170209 ACCESSION NUMBER: 0001415889-23-007669 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230505 FILED AS OF DATE: 20230509 DATE AS OF CHANGE: 20230509 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: AUSTIN ROXANNE S CENTRAL INDEX KEY: 0001061632 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35565 FILM NUMBER: 23903145 MAIL ADDRESS: STREET 1: 200 N SEPULVEDA BLVD STREET 2: PO BOX 956 MS ES/001/A102 CITY: EL SEGUNDO STATE: CA ZIP: 90245 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AbbVie Inc. CENTRAL INDEX KEY: 0001551152 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 320375147 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1 NORTH WAUKEGAN ROAD CITY: NORTH CHICAGO STATE: IL ZIP: 60064 BUSINESS PHONE: (847) 932-7900 MAIL ADDRESS: STREET 1: 1 NORTH WAUKEGAN ROAD CITY: NORTH CHICAGO STATE: IL ZIP: 60064 4 1 form4-05092023_090558.xml X0407 4 2023-05-05 0001551152 AbbVie Inc. ABBV 0001061632 AUSTIN ROXANNE S 1 N. WAUKEGAN ROAD NORTH CHICAGO IL 60064 true false false false 0 Common Stock, $0.01 par value 2023-05-05 4 A 0 1450 0 A 35933 D These are restricted stock units awarded under the AbbVie Amended and Restated 2013 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). Steven L. Scrogham, attorney-in-fact for Roxanne S. Austin 2023-05-09